LEANING CAUTIOUS, NOT CONVINCED (55% Downside)

S&P 500 (SPY): $769.66 (+0.56% daily, -0.44% weekly) NASDAQ (QQQ): $721.25 (+1.27%) VIX: 17.52 10-Yr Yield: 4.99% Gold (GLD): $372.28 Fear & Greed Index: 33.3 (Fear)

ES is up 0.2% and NQ is up 0.3% from Tuesday’s close, giving the pre-open tape a modest positive bias ahead of the FOMC decision. SPY closed Tuesday at $769.66, just below the $770 reference point and above the major $753–$762 support band, while QQQ’s 1.27% advance showed stronger large-cap technology momentum. Participation remains split, with bearish SPY and QQQ gauges contrasting with a neutral IWM gauge and 72 assets rated bullish or strongly bullish. Price discovery will be dominated by the 14:00 ET FOMC decision, followed by major technology earnings after the close and Thursday’s PCE release.

- The pre-open tape is positive, with ES up 0.2% and NQ up 0.3% from Tuesday’s close. - SPY finished at $769.66 and remains above the major $753–$762 support band, which contains 10 confluent levels and 37 prior tests. - The asset screen shows 35 strong-bullish and 37 bullish readings, representing 72 of 153 tracked assets, compared with 36 bearish readings. - Upcoming-quarter S&P 500 earnings are expected to rise 18.8% from a year earlier, with 73% of companies showing growth and 11 of 12 bellwethers above year-ago levels.

- The TRH verdict is MARKET VALUE INTACT — TEMPORARY DIPS, and the live hazard label is DRAWDOWN RISK SEVERE · P* 55% as of October 28, 2026, not a forecast; SPY’s $752.89 invalidation remains the decisive downside line. - The SPY Gauge is bearish at 46.6 and the QQQ Gauge is bearish at 40.1, leaving large-cap momentum vulnerable if Tuesday’s rebound fails to extend. • VIX: closed near $17.52 yesterday; watch yesterday's session high and low as the immediate technical reference for today's trading. - Potential triggers include the FOMC decision at 14:00 ET, Thursday’s PCE release and the November 6 Employment Situation report, with no FOMC print captured yet.

The structural cycle remains in Phase 3, so the AB Portfolio’s defensive four-sleeve framework carries 50% growth, 20% WEEK, 10% income and 20 % defensive. Protection positions qualify through technical momentum rather than automatic allocation, while any unconfirmed defensive lines capacity rests in the rebalancing-cadence line or eligible rotating defensive holdings under the portfolio rules.

The desk reads dips as shallow and temporary while SPY holds 752.89: a read, not a forecast. The model book builds exposure gradually rather than chasing strength, sizes new positions smaller around tier-1 releases and does not initiate leveraged exposure into the FOMC session.

- S&P 500: The $753 support level and $770 resistance reference define the immediate range, with a sustained move above $770 improving momentum and a close below $752.89 invalidating the temporary-dips read. - VIX: The current 17.52 reading is the only validated volatility reference supplied, so the desk will assess movement away from that level without generating unsupported floor or ceiling estimates. - 10-year yield: The 4.99% level is the key rates pivot, with continued pressure above it likely to weigh on duration-sensitive growth while a retreat would ease valuation pressure. - SHC: Suppression capacity is 66 and price pressure is 24 against touch thresholds of S at or below 40 and D at or above 60; the two forces have drifted from the drawdown event and remain 61 points away.

- Before Wednesday’s open, Automatic Data Processing (ADP; consensus EPS 2.78) and Boston Scientific (BSX; consensus EPS 0.76) report, with the desk watching ADP’s operating outlook for evidence of labor-market resilience. - After Wednesday’s close, Alphabet (GOOGL; consensus EPS 2.94), Microsoft (MSFT; consensus EPS 4.71), KLA (KLAC; consensus EPS 1.18), ServiceNow (NOW; consensus EPS 0.56) and FedEx (FDX; consensus EPS 3.24) report, with the desk watching Microsoft’s cloud growth, AI demand and capital-spending commentary. - Before Thursday’s open, Eli Lilly (LLY; consensus EPS 5.38), Mastercard (MA; consensus EPS 5.14), Caterpillar (CAT; consensus EPS 7.12), Merck (MRK; consensus EPS 2.12), Linde (LIN; consensus EPS 4.52), Bristol-Myers Squibb (BMY; consensus EPS 1.28) and Altria (MO; consensus EPS 1.51) report, with the desk watching Eli Lilly’s demand trends and full-year guidance.

Fear at 33.3 and intact support provide potential rebound fuel, but bearish large-cap gauges and the heavy event calendar argue against treating green futures as confirmation. The model-book recommendation is to retain defensive composition, keep new risk smaller through the scheduled releases and require SPY to hold $752.89 before any gradual expansion in exposure.

NEXT REVIEW: Thursday, October 29, 2026